世界のアルツハイマー病治療市場規模・現状・予測2021-2027

【英語タイトル】Global Alzheimers Disease Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0279)・商品コード:QY21APR0279
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:98
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、アルツハイマー病治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体拮抗薬)、用途別市場規模(病院、クリニック)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・アルツハイマー病治療の市場動向
・企業の競争状況、市場シェア
・アルツハイマー病治療の種類別市場規模(バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体拮抗薬)
・アルツハイマー病治療の用途別市場規模(病院、クリニック)
・アルツハイマー病治療の北米市場規模2016-2027(アメリカ、カナダ)
・アルツハイマー病治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・アルツハイマー病治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・アルツハイマー病治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・アルツハイマー病治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(F. Hoffmann-La Roche、Merck、Pfizer、Novartis、Eisai、Actavis、Daiichi Sankyo)
・結論
【レポートの概要】

Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are memory loss, insomnia, repetitive movements, agitation, anxiety, depression and loss of reasoning abilities. All memory and mental functioning may be lost in advanced stages of the disease. Alzheimer’s disease may lead to death. According to National Institute of Aging, Alzheimer’s disease is the common form of dementia. 
Population aging across the globe is a major factor driving the market for Alzheimer’s therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in number of aged population, and is associated with increased prevalence of chronic diseases like dementia. Therapies for AD offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease advancement. Thus, the magnitude of the affected population and lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers. However, identification of the primary reasons and mechanisms involved in AD are is limited. Drug manufacturers have been unable to validate significant clinical benefits of treatment for a numerous of new compounds due to strict regulations. One of the significant trend observed in this market is collaboration of the existing players.  Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates which is further expected to propel the demand.

Market Analysis and Insights: Global Alzheimers Disease Therapeutics Market
The global Alzheimers Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alzheimers Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alzheimers Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alzheimers Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alzheimers Disease Therapeutics market.

Global Alzheimers Disease Therapeutics Scope and Market Size
Alzheimers Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimers Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biomarkers
Cholinesterase Inhibitors
NMDA Receptor Antagonists

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche
Merck
Pfizer
Novartis
Eisai
Actavis
Daiichi Sankyo

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimers Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biomarkers
1.2.3 Cholinesterase Inhibitors
1.2.4 NMDA Receptor Antagonists
1.3 Market by Application
1.3.1 Global Alzheimers Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alzheimers Disease Therapeutics Market Perspective (2016-2027)
2.2 Alzheimers Disease Therapeutics Growth Trends by Regions
2.2.1 Alzheimers Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alzheimers Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Alzheimers Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Alzheimers Disease Therapeutics Industry Dynamic
2.3.1 Alzheimers Disease Therapeutics Market Trends
2.3.2 Alzheimers Disease Therapeutics Market Drivers
2.3.3 Alzheimers Disease Therapeutics Market Challenges
2.3.4 Alzheimers Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alzheimers Disease Therapeutics Players by Revenue
3.1.1 Global Top Alzheimers Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Alzheimers Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Alzheimers Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alzheimers Disease Therapeutics Revenue
3.4 Global Alzheimers Disease Therapeutics Market Concentration Ratio
3.4.1 Global Alzheimers Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimers Disease Therapeutics Revenue in 2020
3.5 Alzheimers Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Alzheimers Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Alzheimers Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimers Disease Therapeutics Breakdown Data by Type
4.1 Global Alzheimers Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Alzheimers Disease Therapeutics Forecasted Market Size by Type (2022-2027)

5 Alzheimers Disease Therapeutics Breakdown Data by Application
5.1 Global Alzheimers Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Alzheimers Disease Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alzheimers Disease Therapeutics Market Size (2016-2027)
6.2 North America Alzheimers Disease Therapeutics Market Size by Type
6.2.1 North America Alzheimers Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Alzheimers Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Alzheimers Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Alzheimers Disease Therapeutics Market Size by Application
6.3.1 North America Alzheimers Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Alzheimers Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Alzheimers Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Alzheimers Disease Therapeutics Market Size by Country
6.4.1 North America Alzheimers Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Alzheimers Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Alzheimers Disease Therapeutics Market Size (2016-2027)
7.2 Europe Alzheimers Disease Therapeutics Market Size by Type
7.2.1 Europe Alzheimers Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Alzheimers Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Alzheimers Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Alzheimers Disease Therapeutics Market Size by Application
7.3.1 Europe Alzheimers Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Alzheimers Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Alzheimers Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Alzheimers Disease Therapeutics Market Size by Country
7.4.1 Europe Alzheimers Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Alzheimers Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alzheimers Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alzheimers Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alzheimers Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Alzheimers Disease Therapeutics Market Size by Type
9.2.1 Latin America Alzheimers Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Alzheimers Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Alzheimers Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Alzheimers Disease Therapeutics Market Size by Application
9.3.1 Latin America Alzheimers Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Alzheimers Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Alzheimers Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Alzheimers Disease Therapeutics Market Size by Country
9.4.1 Latin America Alzheimers Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Alzheimers Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alzheimers Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Alzheimers Disease Therapeutics Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Alzheimers Disease Therapeutics Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Alzheimers Disease Therapeutics Introduction
11.2.4 Merck Revenue in Alzheimers Disease Therapeutics Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Alzheimers Disease Therapeutics Introduction
11.3.4 Pfizer Revenue in Alzheimers Disease Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Alzheimers Disease Therapeutics Introduction
11.4.4 Novartis Revenue in Alzheimers Disease Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Alzheimers Disease Therapeutics Introduction
11.5.4 Eisai Revenue in Alzheimers Disease Therapeutics Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 Actavis
11.6.1 Actavis Company Details
11.6.2 Actavis Business Overview
11.6.3 Actavis Alzheimers Disease Therapeutics Introduction
11.6.4 Actavis Revenue in Alzheimers Disease Therapeutics Business (2016-2021)
11.6.5 Actavis Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Details
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Alzheimers Disease Therapeutics Introduction
11.7.4 Daiichi Sankyo Revenue in Alzheimers Disease Therapeutics Business (2016-2021)
11.7.5 Daiichi Sankyo Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alzheimers Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biomarkers
Table 3. Key Players of Cholinesterase Inhibitors
Table 4. Key Players of NMDA Receptor Antagonists
Table 5. Global Alzheimers Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Alzheimers Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Alzheimers Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Alzheimers Disease Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Alzheimers Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Alzheimers Disease Therapeutics Market Share by Regions (2022-2027)
Table 11. Alzheimers Disease Therapeutics Market Trends
Table 12. Alzheimers Disease Therapeutics Market Drivers
Table 13. Alzheimers Disease Therapeutics Market Challenges
Table 14. Alzheimers Disease Therapeutics Market Restraints
Table 15. Global Alzheimers Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Alzheimers Disease Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Alzheimers Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimers Disease Therapeutics as of 2020)
Table 18. Ranking of Global Top Alzheimers Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Alzheimers Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Alzheimers Disease Therapeutics Product Solution and Service
Table 22. Date of Enter into Alzheimers Disease Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimers Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Alzheimers Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Alzheimers Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Alzheimers Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Alzheimers Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Alzheimers Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Alzheimers Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Alzheimers Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Alzheimers Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Alzheimers Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Alzheimers Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Alzheimers Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Alzheimers Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Alzheimers Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Alzheimers Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Alzheimers Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Alzheimers Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Alzheimers Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Alzheimers Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Alzheimers Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Alzheimers Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Alzheimers Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Alzheimers Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Alzheimers Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Alzheimers Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Alzheimers Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Alzheimers Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Alzheimers Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Alzheimers Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Alzheimers Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Alzheimers Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Alzheimers Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Alzheimers Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Alzheimers Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Alzheimers Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Alzheimers Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Alzheimers Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. F. Hoffmann-La Roche Company Details
Table 63. F. Hoffmann-La Roche Business Overview
Table 64. F. Hoffmann-La Roche Alzheimers Disease Therapeutics Product
Table 65. F. Hoffmann-La Roche Revenue in Alzheimers Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 66. F. Hoffmann-La Roche Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Alzheimers Disease Therapeutics Product
Table 70. Merck Revenue in Alzheimers Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Alzheimers Disease Therapeutics Product
Table 75. Pfizer Revenue in Alzheimers Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Alzheimers Disease Therapeutics Product
Table 80. Novartis Revenue in Alzheimers Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Eisai Company Details
Table 83. Eisai Business Overview
Table 84. Eisai Alzheimers Disease Therapeutics Product
Table 85. Eisai Revenue in Alzheimers Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Eisai Recent Development
Table 87. Actavis Company Details
Table 88. Actavis Business Overview
Table 89. Actavis Alzheimers Disease Therapeutics Product
Table 90. Actavis Revenue in Alzheimers Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Actavis Recent Development
Table 92. Daiichi Sankyo Company Details
Table 93. Daiichi Sankyo Business Overview
Table 94. Daiichi Sankyo Alzheimers Disease Therapeutics Product
Table 95. Daiichi Sankyo Revenue in Alzheimers Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Daiichi Sankyo Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimers Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Biomarkers Features
Figure 3. Cholinesterase Inhibitors Features
Figure 4. NMDA Receptor Antagonists Features
Figure 5. Global Alzheimers Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Alzheimers Disease Therapeutics Report Years Considered
Figure 9. Global Alzheimers Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Alzheimers Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Alzheimers Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Alzheimers Disease Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Alzheimers Disease Therapeutics Market Share by Players in 2020
Figure 14. Global Top Alzheimers Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimers Disease Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Alzheimers Disease Therapeutics Revenue in 2020
Figure 16. Global Alzheimers Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Alzheimers Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Alzheimers Disease Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Alzheimers Disease Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Alzheimers Disease Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Alzheimers Disease Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Alzheimers Disease Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Alzheimers Disease Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Alzheimers Disease Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Alzheimers Disease Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Alzheimers Disease Therapeutics Market Share by Region (2016-2027)
Figure 38. China Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Alzheimers Disease Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Alzheimers Disease Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Alzheimers Disease Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Alzheimers Disease Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Alzheimers Disease Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Alzheimers Disease Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Alzheimers Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2016-2021)
Figure 61. Eisai Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2016-2021)
Figure 62. Actavis Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2016-2021)
Figure 63. Daiichi Sankyo Revenue Growth Rate in Alzheimers Disease Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


【掲載企業】

F. Hoffmann-La Roche、Merck、Pfizer、Novartis、Eisai、Actavis、Daiichi Sankyo

★調査レポート[世界のアルツハイマー病治療市場規模・現状・予測2021-2027] (コード:QY21APR0279)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアルツハイマー病治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆